Concepedia

Publication | Closed Access

BR55: A Lipopeptide-Based VEGFR2-Targeted Ultrasound Contrast Agent for Molecular Imaging of Angiogenesis

DOI

260

Citations

20

References

2010

Year

Sibylle Pochon, Isabelle Tardy, Philippe Bussat, Thierry Bettinger, Jean Brochot, Mathew von Wronski, Lisa Passantino, Michel Schneider
Investigative Radiology

Abstract

VEGFR2-targeted ultrasound contrast agents such as BR55 will likely prove useful in human for the early detection of tumors as well as for the assessment of response to specific treatments.

References

YearCitations

Page 1